Robotic Surgery
Since its first introduction in 2005,
Severance Hospital performed over
40,000 robotic surgeries using da
Vinci robotic surgical system as of
December, 2023, which is the world’s first achievement as a single
institution.
Although robotic surgery is cutting-edge medical technology, it is usually employed in limited cases, such as prostate cancer.
However, Severance has garnered astonishing success and widened the horizon of robotic surgery by operating on patients with thyroid cancer, stomach cancer, and colorectal cancer.
Furthermore, Severance has introduced this technology to ear, nose, and throat (ENT), open-heart surgery, cardiovascular surgery, obstetrics & gynecology, and neurosurgical fields.
Robotic surgery statistics
at Severance Hospital
(July 2005 ~ November 2023)
Severance Robot and MIS
(Minimally Invasive surgery) Center
Severance established the Asia-Pacific Education Center, which specializes in robotic operations.
With the support from da Vinci surgical system creator Intuitive Surgical Inc., Severance is increasingly developing its capacity for technological advancements.
Local doctors and nurses from 10 major universities as well as large-scale hospitals in the U.S., and over 600 doctors from across the world have visited Severance to observe robotic surgeries.
Our Successes
Today, an estimated 96% of all prostate cancer patients that underwent robotic operations are disease free. Robotic surgery has thus become standard in treating all prostate cancer cases.
At Severance Hospital, prostate cancer surgeries account for 26% of all robotic procedures. From 2005 to 2023, the hospital observed a notable increase in the number of robotic surgeries for prostate cancer, with the total surpassing 10,100 surgeries.
The success of these robotic surgical procedures has enabled the hospital not just to match but to surpass the success rates of distinguished hospitals worldwide.